— Preclinical model data expected to support development of small diameter HAV to treat patients with coronary artery disease– — Small-diameter HAV observed to maintain patency and exhibit host-cell remodeling at six months post-implantation in a non-human primate model– –Results […]
Coronary/Structural Heart
Nuwellis Announces the Submission of the AVOID-HF Clinical Analysis as a Late Breaking Clinical Trial at HFSA
The Finkelstein-Schoenfeld Method of Win Ratios Analysis Provides New Insights Into Superiority of Ultrafiltration over Diuretics in Treating Fluid Overloaded Heart Failure Patients Resistant to Diuretics MINNEAPOLIS, July 26, 2022 (GLOBE NEWSWIRE) — Nuwellis, Inc. (Nasdaq: NUWE) a commercial-stage company focused on […]
CinCor Pharma Announces Last Patient Randomized in Phase 2 HALO Trial and Initiation of Long-Term Extension Study for Baxdrostat, a Selective Aldosterone Synthase Inhibitor, in Uncontrolled Hypertension
Open Label Extension Study Will Evaluate Baxdrostat for Up to 52 Weeks Topline Data for Phase 2 HALO Trial Expected in 2H 2022 Topline Data for Phase 2 BrigHtn Trial Expected in August 2022 WALTHAM, Mass., July 26, 2022 (GLOBE […]
First German EVBA Procedure is Performed with New Heart Failure Therapy Approach
Latest Data and Live Broadcast Show Promise of Vascular Dynamics’ MobiusHD Device IRVINE, Calif.–(BUSINESS WIRE)–Vascular Dynamics, Inc. (VDI), a privately held medical device company focused on developing game-changing endovascular device-based solutions for patients suffering from heart failure, announced that the […]
Soleo Health Selected by Novartis as Limited Drug Distribution Partner for Administration of LEQVIO®
Company to Distribute Recent FDA-Approved Treatment for Reducing Bad Cholesterol FRISCO, Texas–(BUSINESS WIRE)–Soleo Health, an innovative leader and national provider of complex specialty pharmacy services, announced today it has been selected as a limited distribution partner for cardiovascular drug LEQVIO®, manufactured […]
WERFEN ANNOUNCES WORLDWIDE COMMERCIAL RELEASE OF GEMWEB® LIVE REAL-TIME ONSCREEN VIEWER
— Designed to Enable Time-Critical Clinical Decisions in Cardiac Surgery — BEDFORD, Mass., July 25, 2022 /PRNewswire/ — Werfen today announced the worldwide commercial release of GEMweb Live, a real-time onscreen viewer of diagnostic test results for cardiac surgical procedures. Comprehensive, rapid […]
Vizient Announces Strategic Partnership with Mpirik to Improve Care, Health Equity in Cardiology with Help From AI
IRVING, Texas–(BUSINESS WIRE)–Vizient, Inc., the nations’ largest member-driven health care performance improvement company, today announced a strategic partnership agreement with Mpirik, a cloud-based care pathway software company focused on cardiac care, that will enable physicians to make more informed decisions on […]
NewAmsterdam Pharma Holding B.V. and Frazier Lifesciences Acquisition Corporation Announce Merger Agreement to Create Publicly Listed Company Focused on Transformative Oral Therapies for Major Cardiometabolic Diseases
– Leading institutional investors commit approximately $235 million through an oversubscribed and upsized private investment in public equity (“PIPE”) led by Frazier Healthcare Partners and Bain Capital Life Sciences – – Total proceeds expected to bring pro forma cash balance to at least $470 million; expected […]
MemorialCare Long Beach Medical Center is Nationally Recognized with American Heart Association/American Stroke Association…
MemorialCare Long Beach Medical Center is Nationally Recognized with American Heart Association/American Stroke Association’s Gold Plus Awards for Heart Failure, Stroke Care, and Diabetes LONG BEACH, Calif., July 21, 2022 /PRNewswire/ — MemorialCare Long Beach Medical Center has received the American Heart Association’s Get […]
dal-GenE Phase 3 Cardiovascular Precision Medicine Outcomes Trial Results Published in European Heart Journal
Trial was negatively impacted by the COVID-19 pandemic and did not meet the primary endpoint. However, the results validate the interaction between dalcetrapib treatment and AA genotype at variant rs1967309 in the ADCY9 gene. LONDON and MONTREAL, July 21, 2022 […]